UK markets closed

Sotera Health Company (SHC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.04-0.29 (-2.56%)
At close: 04:00PM EDT
11.04 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.13B
Enterprise value 5.21B
Trailing P/E 58.11
Forward P/E 15.34
PEG ratio (5-yr expected) 1.28
Price/sales (ttm)2.91
Price/book (mrq)7.28
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.09
52-week change 3-27.70%
S&P500 52-week change 326.27%
52-week high 319.40
52-week low 310.71
50-day moving average 312.05
200-day moving average 314.42

Share statistics

Avg vol (3-month) 31.96M
Avg vol (10-day) 31.47M
Shares outstanding 5283.07M
Implied shares outstanding 6283.07M
Float 8127.58M
% held by insiders 12.41%
% held by institutions 182.71%
Shares short (30 Apr 2024) 410.51M
Short ratio (30 Apr 2024) 410.03
Short % of float (30 Apr 2024) 48.19%
Short % of shares outstanding (30 Apr 2024) 43.71%
Shares short (prior month 28 Mar 2024) 410.86M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 5.09%
Operating margin (ttm)24.53%

Management effectiveness

Return on assets (ttm)7.07%
Return on equity (ttm)13.88%

Income statement

Revenue (ttm)1.08B
Revenue per share (ttm)3.83
Quarterly revenue growth (yoy)12.50%
Gross profit (ttm)N/A
EBITDA 527.35M
Net income avi to common (ttm)54.57M
Diluted EPS (ttm)0.19
Quarterly earnings growth (yoy)122.50%

Balance sheet

Total cash (mrq)261.55M
Total cash per share (mrq)0.92
Total debt (mrq)2.35B
Total debt/equity (mrq)546.40%
Current ratio (mrq)3.20
Book value per share (mrq)1.52

Cash flow statement

Operating cash flow (ttm)-171.9M
Levered free cash flow (ttm)-258.95M